valeant pharmaceutical ceo is just as thechair, companies facing questions about their accounting practices. can he turn around the drugmaker's stock that has lost two thirds of its value since august? case prepares to make its as they prepare to tell lawmakers on tuesday that it is their job to decide the encryption issue, not the job of courts. can they win in the courtroom and in the court of public appeals? let's head to the markets desk, first off. julie: down off the highs for the day, we initially saw not with the change people's reserve of china trying to add stimulus there. not seeing much reaction in the united states. moved higher with oil prices on the day. the low-volume situation continues. not only lower volume today, but a very tight range for the s&p 500. this index looks at the daily spread in the s&p and it looks like it will be at its lowest this year unless something changes, of course, in the next couple of hours of trading. you have seen not a lot of movement in this session today. that has been more true over the past several weeks. matt: we have seen some interestin